Pharmaceutical formulators evaluating direct compression tablet manufacturing face a recurring set of technical hurdles: poor compressibility of active ingredients, inconsistent tablet hardness, slow disintegration, and unstable drug release profiles. Selecting the right cellulose-based excipients is central to solving these challenges, and Shanghai Runkey Biotech Co., Ltd., operating under the...